Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-23

Clinical Trial Update: Oral Fexinidazole Dosing Regimens for the Treatment of Adults With Chronic Indeterminate Chagas Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating oral fexinidazole dosing regimens for adults with chronic indeterminate Chagas disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fexinidazole (fexinidazole)

Snippet

Sponsor: Drugs for Neglected Diseases | Conditions: Chagas' Disease (Chronic) Nos | Phase 2 | Status: COMPLETED